Akèy › Skleroderm Difize › Maryland › Baltimore
Etid klinik pou Skleroderm Difize nan Baltimore, MD
5 etid pou Skleroderm Difize ap chèche patisipan nan sit nan ak bò kote Baltimore (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Sildenafil for Early Pulmonary Vascular Disease in Scleroderma
Ap rekriteFaz 2
- Johns Hopkins, Baltimore
EncompaSSc: Evaluation of MTX-474 in Participants With Diffuse Cutaneous Systemic Sclerosis (dcSSc)
Ap rekriteFaz 2
- Johns Hopkins University, Baltimore
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
Ap rekriteFaz 1
- Johns Hopkins Hospital, Baltimore
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
Ap rekriteFaz 2/3
- GSK Investigational Site, Baltimore
Platform Clinical Study for Conquering Scleroderma
Ap rekriteFaz 2
- Johns Hopkins University School of Medicine, Baltimore
Etid Skleroderm Difize nan lòt vil
- New York City, NY8 etid
- Ann Arbor, MI7 etid
- Chicago, IL7 etid
- Durham, NC6 etid
- Los Angeles, CA6 etid
- Houston, TX5 etid
- Boston, MA5 etid
- Kansas City, KS4 etid
- Philadelphia, PA4 etid
- New Orleans, LA4 etid
- Pittsburgh, PA4 etid
- Dallas, TX3 etid
Lòt etid nan Baltimore
- Kansè Poumon ki pa ti selil60 etid
- Kansè nan tete47 etid
- Kansè pwostat42 etid
- Kansè poumon40 etid
- Kansè (tout kalite)38 etid
- Kansè pankreyas32 etid
- Kansè kolorektal31 etid
- Kansè Metastatik28 etid
- Obèsite25 etid
- Kansè vejik24 etid
- Ensifizyans kadyak24 etid
- Akidan serebavaskilè22 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.